Pharma Journalist -

Evotec AG announced that CENTOGENE AG and Evotec entered into a global strategic collaboration agreement for joint drug discovery projects, developing compounds to treat rare genetic…
Read More...

Novartis announced that the European Commission (EC) has approved Kymriah (tisagenlecleucel, formerly CTL019). The approved indications are for the treatment of pediatric and young…
Read More...

Adverum Biotechnologies announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ADVM-053, a preclinical gene therapy candidate…
Read More...

JW Pharmaceutical and LEO Pharma A/S announced that they have signed a global licensing agreement for JWP’s novel atopic dermatitis drug candidate, JW1601, under which, LEO Pharma, a…
Read More...

Tolero Pharmaceuticals has entered into a clinical research collaboration with AbbVie, a research-based global biopharmaceutical company, exploring the potential of combination therapy…
Read More...

Roche announced that the China National Drug Administration (CNDA) has granted marketing authorisation for Alecensa (alectinib) as a monotherapy treatment for patients with anaplastic…
Read More...

AstraZeneca announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Tagrisso(osimertinib) for the 1st-line treatment of patients with inoperable or…
Read More...

Innovate Biopharmaceuticals announced it signed an agreement with Amarex Clinical Research to provide data management and biostatistics for its planned Phase 3 celiac disease trial.…
Read More...

PTC Therapeutics announced that it has successfully completed the acquisition of Agilis Biotherapeutics, Inc., a private biotechnology company focused on the advancement of innovative…
Read More...

bluebird bio and Gritstone Oncology announced a collaboration to research, develop and commercialize products for the treatment of cancer using cell therapy. Gritstone Oncology will…
Read More...